Yuko Takahashi, Kumiko Kida, Meiko Nishimura, Kaori Terata, Manabu Futamura, Atsushi Yoshida, Tadahiko Shien, Takayuki Ueno, Toshimi Takano. "OPERETTA: A phase II study evaluating neoadjuvant and adjuvant olaparib plus pembrolizumab following platinum-based chemotherapy plus pembrolizumab for germline BRCA mutated triple negative breast cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps632